The evolution opens doors for the treatment of neurotrophic keratitis and beyond.
Flavio Mantelli, MD, PhD
Advertisement
Articles by Flavio Mantelli, MD, PhD
Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.
Advertisement
Latest Updated Articles
Dompe's past developments, continual progress in NGF applicationsFebruary 8th 2023
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Georgia university receives state funding for state's first college of optometry
2
Practical tips and tricks: Drs Jeffrey J. Walline, Erin Tomiyama weigh in on myopia management
3
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
4
Recent study findings may prove previous estimations of retinal cell communication, low-light vision
5